JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Interpretive Summary
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammon, H. M.
Right arrow Articles by Donkin, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammon, H. M.
Right arrow Articles by Donkin, S. S.
J. Dairy Sci. 88:2107-2116
© American Dairy Science Association, 2005.

Effects of Dexamethasone and Growth Hormone Treatment on Hepatic Gluconeogenic Enzymes in Calves

H. M. Hammon1,*, C. Philipona1, Y. Zbinden1, J. W. Blum1 and S. S. Donkin2

1 Division of Nutrition and Physiology, Institute of Animal Genetics, Nutrition and Housing, Vetsuisse Faculty, University of Berne, CH-3012 Berne, Switzerland
2 Department of Animal Science, Purdue University, West Lafayette, IN 47907

Corresponding author: H. M. Hammon; e-mail: hammon{at}fbn-dummerstorf.de.

The hypothesis was tested that dexamethasone (DX) and bovine somatotropin (bST) alter expression or activity of gluconeogenic enzymes in neonatal calves. Holstein dairy calves (n = 24) were randomly divided in 4 groups and were treated with saline (control group), with DX at 30 µg/kg body weight per d (CDX), with 500 mg of sustained-release recombinant bST every 14 d (CbST), and with the combination of DX and bST from d 3 through 42 of life (CbSTDX). Plasma glucose and insulin concentrations were elevated throughout the study in CbSTDX, and insulin concentrations were elevated in CDX from d 7 to 28. Treatment with DX and the combination of DX and bST increased plasma glucagon concentrations from d 14 to 42, but decreased plasma cortisol concentrations on d 7 and 14 when compared with control calves. In liver, phosphoenolpyruvate carboxykinase (PEPCK) mRNA levels were reduced in CDX and CbSTDX when compared with control calves or CbST. The activity of PEPCK on d 14 was higher in CbSTDX compared with control calves. Pyruvate carboxylase mRNA levels were decreased on d 7 in CDX and CbSTDX. Pyruvate carboxylase activities on d 14 and 28 were lower in CDX and CbSTDX than in control calves or CbST. These data indicate an age-dependent response to DX for blood metabolites, expression and activities of hepatic PEPCK and pyruvate carboxylase, and for effects of bST, suggesting that glucocorticoid status is important.

Key Words: glucocorticoid • bovine somatotropin • gluconeogenesis • calf

Abbreviation key: CbST = calves treated with bST, CbSTDX = calves treated with dexamethasone and bST, DX = dexamethasone, CDX = calves treated with dexamethasone, PC = pyruvate carboxylase, PEPCK = phosphoenolpyruvate carboxykinase




This article has been cited by other articles:


Home page
J DAIRY SCIHome page
S. Haga, S. Fujimoto, T. Yonezawa, K. Yoshioka, H. Shingu, Y. Kobayashi, T. Takahashi, Y. Otani, K. Katoh, and Y. Obara
Changes in Hepatic Key Enzymes of Dairy Calves in Early Weaning Production Systems
J Dairy Sci, August 1, 2008; 91(8): 3156 - 3164.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
G. Ferreira and W. P. Weiss
Effect of Biotin on Activity and Gene Expression of Biotin-Dependent Carboxylases in the Liver of Dairy Cows
J Dairy Sci, March 1, 2007; 90(3): 1460 - 1466.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Dairy Science Association ®.